Search

Symantha Wilson was crushed when chemotherapy quit fighting her lymphoma — and thrilled when immuno¬therapy beat back the cancer. But why doesn’t immunotherapy help more people? MSK researchers are finding answers.

… Friday, April 1, 2022 Symantha Wilson knows she is one of the lucky ones. The 26-year-old Long Island resident was nearing the end of a six-month chemotherapy regimen for stage 2 Hodgkin lymphoma last June. The treatment had been very effective, wiping out most of the cancer cells. But with just over

More sugar available for immune cells could mean better immune responses against cancer.

… Monday, February 15, 2021 Summary New research from Memorial Sloan Kettering scientists suggests that a way to improve immunotherapy is by altering immune cells’ access to sugar. Cancer cells and immune cells share something in common: They both love sugar. Sugar is an important nutrient. All cells use

Like all researchers, nurse scientists design studies, accumulate data, and publish their findings. Their concentration in nursing means that they’re focused on patient needs, perspectives, and outcomes. Whereas a medical doctor might study how a drug is working, a nurse scientist may take a more holistic view of how a treatment affects a patient’s and their family’s quality of life.

… Friday, January 13, 2023 The mission for Kristen Fessele, PhD, RN, ANP-BC, AOCN, is personal. Her mother had survived cancer. But Dr. Fessele, a nurse scientist at Memorial Sloan Kettering Cancer Center (MSK), wanted to see her more than just survive — she wanted to see her thrive again. Dr. Fessele

Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood tests and clinical data.

… Monday, January 6, 2025 Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors — a type of immunotherapy — using only routine blood tests and clinical data. The artificial intelligence–based

There is a clear and unmet need for less invasive and more accurate methods for diagnosing lung cancer. A promising innovation under investigation at Memorial Sloan Kettering Cancer Center (MSK) is the electronic nose (e-nose), which evaluates volatile organic compounds (VOCs) in exhaled breath. The e-nose platform detects a lung cancer-associated “breathprint” in breath from individuals with lung cancer.

… Friday, September 15, 2023 There is a clear and unmet need for less invasive and more accurate methods for diagnosing lung cancer. A promising innovation under investigation at Memorial Sloan Kettering Cancer Center (MSK) is the electronic nose (e-nose), which evaluates volatile organic compounds (VOCs

MSK researchers shed light on how the number of mutations in a tumor affect a patient’s response to immunotherapy drugs.

… Monday, February 22, 2021 Summary The level of genetic mutations in a tumor, called tumor mutational burden (TMB), has been used to predict how people with cancer will respond to immunotherapy. But MSK physician-scientist Luc Morris explains that important aspects of TMB’s clinical relevance have needed

Find out why you still need your routine mammogram, even during COVID-19.

… Wednesday, October 6, 2021 At a time when too many women delayed their yearly mammogram because of the pandemic, Katie Gay is very glad she did not miss hers. She knew that because of her dense breasts, regular screenings were critical. After her routine mammogram in February 2021, Katie found out she

Learn about Madeleine Ruff’s inspiring story, from being treated at MSK Kids for a rare cancer as a teenager to managing clinical trials for new cancer treatments as an adult.

… Monday, June 10, 2024 Madeleine Ruff, MHA, helps manage  clinical trials that test new cancer treatments to see how well they work. It’s an important job but one that doesn’t seem all that unusual, until you learn that Maddy started her career as a professional rock ’n’ roll and jazz singer. It’s certainly

More than 50,000 runners traversed 26.2 miles across five boroughs for the TCS New York City Marathon. Among them were 925 participants who ran in support of Fred’s Team. Fred’s Team is the running program for Memorial Sloan Kettering Cancer Center (MSK), which is dedicated to moving closer to a world without cancer.

… Friday, November 9, 2018 More than 50,000 runners traversed 26.2 miles across five boroughs for the TCS New York City Marathon. Among them were 925 participants who ran in support of Fred’s Team . Fred’s Team is the running program for Memorial Sloan Kettering Cancer Center (MSK), which is dedicated

… Friday, March 21, 2025 A newly published pooled analysis of the Organ Preservation in Patients with Rectal Adenocarcinoma (OPRA) trial and the CAO/ARO/AIO-12 trial by the German Rectal Cancer Study Group has confirmed the safety and benefits of the watch-and-wait strategy for patients with locally advanced